← Open Payments lookup

MACKENZIE WOLFE: Open Payments

NPI 1770296345 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$671 in 36 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $671

Food & beverage: $671
CompanyPaymentsAmount
ABBVIE INC.14$285
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$156
E.R. Squibb & Sons, L.L.C.3$56
Vanda Pharmaceuticals Inc.2$37
Luye Pharma (USA) Ltd.1$26
Axsome Therapeutics, Inc.1$22
Supernus Pharmaceuticals, Inc.1$22
Tris Pharma Inc1$19
Neurocrine BioSciences, Inc.1$16
Teva Pharmaceuticals USA, Inc.1$15

Products named: VRAYLAR, CAPLYTA, COBENFY, FANAPT, ERZOFRI EXTENDED-RELEASE, Auvelity, Qelbree, Dyanavel XR.

Industry payments across NV — which companies pay providers there.